Myungmoon Phar (017180)

Currency in KRW
1,215
-25(-2.02%)
Closed·
Advertisement
017180 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,1811,237
52 wk Range
1,0002,055
Key Statistics
Bid/Ask
1,211.00 / 1,215.00
Prev. Close
1,240
Open
1,230
Day's Range
1,181-1,237
52 wk Range
1,000-2,055
Volume
26.98K
Average Volume (3m)
415.05K
1-Year Change
-28.149%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
017180 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Earnings

Latest Release
15/05/2026
EPS / Forecast
-23.98 / --
Revenue / Forecast
48B / --
EPS Revisions
Last 90 days

Compare 017180 to Peers and Sector

Metrics to compare
017180
Peers
Sector
Relationship
P/E Ratio
13.4x−0.6x−0.3x
PEG Ratio
0.070.000.00
Price/Book
0.4x0.6x2.6x
Price / LTM Sales
0.2x0.7x3.1x
Upside (Analyst Target)
-52.0%47.6%
Fair Value Upside
Unlock29.6%5.6%Unlock

MYUNGMOON Pharm co.,Ltd engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally. It offers prescription drugs, including anti osteoarthritis, anti-inflammatory analgesics, antiphlogistic enzymes, muscle relaxant, anti rheumarthritis, antibiotics and antifungal, respiratory agents, GI therapeutics, circulation agents, anti-hypertension agents, antidiabetic drugs, narcotics, anesthetic agents, central nervous system products, female hormone products, osteoporotic therapeutics, urogentital agents, adrenocortical hormone products, oncology agents, other preparations, and anti-obesity agents for pharmacotherapy. The company also provides OTC products, such as antinausants, genitourinary system products, anti gum disease products, hepatics, parasiticides, cathartic, antidiarrheal agents, digestive system products, multiple vitamin products, eye nutrition products, eye drops, blood circulation products, circulatory solvents, skin external preparations, and topical analgesic products. In addition, it offers health supplements, quasi drugs, and blended juices. MYUNGMOON Pharm co.,Ltd was founded in 1983 and is headquartered in Seoul, South Korea.

Employees
291

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.17K0.03%12.36M
Other Institutional Investors
1.31K0.00%1.60M
Public Companies & Retail Investors
33.42M99.97%40.61B
Total
33.43M100.00%40.62B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.03%10,17312,360
Dimensional Funds ICVC - Dimensional Emerging Markets Core Equity Fund0.02%5,1736,285

FAQ

What Is the Myungmoon Phar (Seoul: 017180) Share Price Today?

The Myungmoon Phar stock price today is 1,215 KRW.

What Stock Exchange Does Myungmoon Phar (017180) Trade On?

Myungmoon Phar is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Myungmoon Phar?

The stock symbol (also called a 'ticker') for Myungmoon Phar is "017180."

What Is the Current Myungmoon Phar Market Capitalisation?

As of today, Myungmoon Phar (Seoul: 017180) market cap is 40.62B KRW.

What Is Myungmoon Phar's (017180) Earnings Per Share (TTM)?

The Myungmoon Phar EPS is currently 90 (Trailing Twelve Months).

Is 017180 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Myungmoon Phar moving averages and other technical indicators, the daily buy/sell signal for 017180 stock is Neutral.

How Many Times Has Myungmoon Phar Stock Split?

Myungmoon Phar has split 14 times. (See the 017180 stock split history page for full effective split date and price information.)

How Many Employees Does Myungmoon Phar Have?

Myungmoon Phar has 291 employees, based on their latest Companies House report.

What is the current trading status of Myungmoon Phar (Seoul: 017180)?

As of 22/08/2026, Myungmoon Phar (017180) is trading at a share price of 1,215 KRW, with a previous close of 1,240 KRW. The stock has fluctuated within a day range of 1,181 KRW to 1,237 KRW, while its 52-week range spans from 1,000 KRW to 2,055 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.